The New York Times opinion piece notes that China has stepped up its investments in biotechnology, seeking not only to strengthen its domestic industry but also to project power and influence internationally.
According to the analysis, this strategy includes the development of advanced capabilities in genetic, pharmaceutical, and agricultural research, which represents a direct challenge to the United States' dominant position in the sector.
The text also warns of the need to establish clear rules of transparency, international cooperation, and ethical safeguards to avoid risks associated with genetic manipulation and the misuse of emerging technologies.